Home Category Region Publishers About Us Contact Us
Japanese Korean Chinese
Home > Market Research Report > Pharmaceutical > Cancer > European Head and Neck Cancer Therapeutics Markets
Category
Pharmaceutical (4988)
Bone Disease Treatment (46)
Cancer (883)
Diabetes (159)
Drug Delivery System (184)
Drug Discovery (1403)
Generic Drugs (128)
Infectious Disease (406)
Mental Disease (98)
Neurodegenerative Disease (180)
Obesity Treatment (49)
OTC Drug (149)
Pharmaceutical Companies (561)
Prescription Drugs (120)
Regulation (122)
Vaccines (178)
Veterinary Medicine (28)
Market Research Report

European Head and Neck Cancer Therapeutics Markets

Published by Frost & Sullivan
Published August, 2007 Product code 54134
Content info 124 Pages
Price
US $ 6500 Web Access (Regional License)
US $ 7000 Hard Copy & Web Access (Regional License)


European Head and Neck Cancer Therapeutics Markets published by Frost & Sullivan in August, 2007. This report consists of 124 Pages and the price starts from US $ 6500.

Introduction

Abstract

This Frost & Sullivan research service titled European Head and Neck Cancer Therapeutics Markets provides market drivers, restraints and revenue forecasts for this market. In this research, Frost & Sullivan' s expert analysts thoroughly examine the chemotherapy and targeted therapies markets.

Table of Contents

1. EXECUTIVE SUMMARY

Overview

  • Overview of the Head and Neck Cancer Therapeutics Market

2. GLOSSARY OF TERMS

List of Terms

  • Abbreviations

3. MARKET OVERVIEW

Introduction

  • Disease Characteristics
  • Epidemiology

Market Definition and Segmentation

  • Definition
  • Segmentation

4. RESEARCH METHODOLOGY

Research Objectives and Scope

  • Methodology
  • Assumptions and Limitations

5. INDUSTRY CHALLENGES

Industry Challenges for the European Head and Neck Cancer Therapeutics Markets

  • Challenges Faced by Pharmaceutical Companies

6. TOTAL EUROPEAN HEAD AND NECK CANCER THERAPEUTICS MARKET

Overview and Definitions

  • Introduction
  • Market Drivers
  • Market Restraints
  • Current Therapeutic Options
  • Future Therapeutic Approaches
  • Current Treatment Guidelines
  • Pricing Trends
  • Market Engineering Measurement Analysis

Competitive Analysis

  • Profiles of Key Industry Participants and Market Share Analysis
  • Pipeline Analysis

7. TOTAL FORECASTS FOR THE EUROPEAN HEAD AND NECK CANCER THERAPEUTICS MARKET

Forecasts

  • Patient Forecasts
  • Market Revenue Forecasts
  • Geographical Trends
  • Forecasts of Recent Entrants - Erbitux

8. PRICING AND REIMBURSEMENTS

Pricing and Reimbursement Issues

  • Pricing and Reimbursement

9. STRATEGIC RECOMMENDATIONS FOR THE EUROPEAN HEAD AND NECK CANCER THERAPEUTICS MARKET

Market Engineering Recommendations

  • Strategic Recommendations

10. DATABASE OF KEY INDUSTRY PARTICIPANTS

Key Industry Participants

  • Key Participants in the Head and Neck Cancer Therapeutics Market

11. DECISION SUPPORT DATABASES

Habitual Indicators

  • Prevalence of Smokers
  • Prevalence of Male Smokers
  • Prevalence of Female Smokers
  • Alcohol Consumption

Healthcare Expenditure

  • Expenditure
  • Pharmaceutical R&D Expenditure

Demography

  • Female Population Aged 65 Years and Above
  • Male Population Aged 65 Years and Above
  • Population Aged 65 Years and Above
  • Percent of Population Aged 65 Years and Above
Back to Top